HB 1772 (2026)
Allow some ibogaine prescriptions
This bill is still active.
Last updated 2026-03-18 9:34 pm
Summary:
Allows New Hampshire to participate in a multistate consortium to conduct clinical trials using ibogaine as an investigational new drug for the treatment of substance use disorder and other conditions.
The House rewrote the bill to instead allow health care providers to prescribe ibogaine "for investigational use only."
Status:
Public Hearing Date:
03/25/2026 10:00 am
Public Hearing Location:
SH Room 100
House Voting Date:
03/11/2026
The data you see here is pulled daily from official government databases. The bill summary is created by Citizens Count staff. Learn more about our methodology for summarizing and updating bills. Visit the official New Hampshire government website for a deep-dive on this bill.
Browse related articles and bills:
